| Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 315 | 2019 |
| Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ... The Lancet Neurology 17 (4), 335-346, 2018 | 197 | 2018 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 176 | 2020 |
| EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease S Gaubert, F Raimondo, M Houot, MC Corsi, L Naccache, J Diego Sitt, ... Brain 142 (7), 2096-2112, 2019 | 171 | 2019 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 136 | 2019 |
| Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years A Bertrand, J Wen, D Rinaldi, M Houot, S Sayah, A Camuzat, C Fournier, ... JAMA neurology 75 (2), 236-245, 2018 | 123 | 2018 |
| Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B M Houot, Y Ngo, M Munteanu, S Marque, T Poynard Alimentary pharmacology & therapeutics 43 (1), 16-29, 2016 | 117 | 2016 |
| Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease E Cavedo, MJ Grothe, O Colliot, S Lista, M Chupin, D Dormont, M Houot, ... Scientific reports 7 (1), 11706, 2017 | 94 | 2017 |
| Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 86 | 2018 |
| Low cognitive awareness, but not complaint, is a good marker of preclinical Alzheimer’s disease F Cacciamani, C Tandetnik, G Gagliardi, H Bertin, MO Habert, H Hampel, ... Journal of Alzheimer's Disease 59 (2), 753-762, 2017 | 66 | 2017 |
| Neurite density is reduced in the presymptomatic phase of C9orf72 disease J Wen, H Zhang, DC Alexander, S Durrleman, A Routier, D Rinaldi, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 387-394, 2019 | 59 | 2019 |
| Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds MO Habert, H Bertin, M Labit, M Diallo, S Marie, K Martineau, A Kas, ... Annals of nuclear medicine 32, 75-86, 2018 | 51 | 2018 |
| Characterization of recessive Parkinson disease in a large multicenter study S Lesage, A Lunati, M Houot, SB Romdhan, F Clot, C Tesson, G Mangone, ... Annals of neurology 88 (4), 843-850, 2020 | 47 | 2020 |
| Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease PA Chiesa, E Cavedo, A Vergallo, S Lista, MC Potier, MO Habert, ... Alzheimer's & Dementia 15 (7), 940-950, 2019 | 47 | 2019 |
| Biomarker-guided clustering of Alzheimer's disease clinical syndromes N Toschi, S Lista, F Baldacci, E Cavedo, H Zetterberg, K Blennow, ... Neurobiology of aging 83, 42-53, 2019 | 45 | 2019 |
| Association of cerebrospinal fluid α‐synuclein with total and phospho‐tau181 protein concentrations and brain amyloid load in cognitively normal subjective … A Vergallo, RS Bun, N Toschi, F Baldacci, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 14 (12), 1623-1631, 2018 | 42 | 2018 |
| Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19 V Lambrecq, A Hanin, E Munoz-Musat, L Chougar, S Gassama, ... JAMA Network Open 4 (3), e211489-e211489, 2021 | 41 | 2021 |
| Altered dynamics of neurovascular coupling in CADASIL C Huneau, M Houot, A Joutel, B Béranger, C Giroux, H Benali, H Chabriat Annals of clinical and translational neurology 5 (7), 788-802, 2018 | 41 | 2018 |
| Disrupted white matter structural networks in healthy older adult APOE ε4 carriers–An international multicenter DTI study E Cavedo, S Lista, K Rojkova, PA Chiesa, M Houot, K Brueggen, ... Neuroscience 357, 119-133, 2017 | 37 | 2017 |
| Quality of life in functional movement disorders is as altered as in organic movement disorders T Gendre, G Carle, F Mesrati, C Hubsch, T Mauras, E Roze, M Houot, ... Journal of psychosomatic research 116, 10-16, 2019 | 36 | 2019 |
